HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
TuHURA Biosciences, Inc./NV
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.78+0.02 (+1.14%)
Close on Oct 19, 2026
- Market cap
- $113.86M
- P/E (TTM)
- –
- Dividend yield
- –
TuHURA Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Market Cap | $113.43M | $166.30M |
| Enterprise Value | $112.44M | $88.19M |
| PB Ratio | 6.13 | 2.03 |
| P/TBV Ratio | 14.61 | 2.29 |
Income (trailing twelve months)
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Net Income | -$30.62M | -$22.46M |
| EPS (Diluted) | -$0.54 | -$0.83 |
Returns
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -161.4% | -53.2% |
| Return on Assets (ROA) | -92.3% | -40.9% |
Balance sheet
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $995.98K | $61.43M |
| Net Cash (Debt) | $995.98K | $15.35M |
| Net Cash Per Share | $0.02 | $0.66 |
| Equity (Book Value) | $18.50M | $49.09M |
| Book Value Per Share | $0.29 | $1.37 |
| Tangible Book Value | $7.76M | $23.52M |
| Working Capital | -$7.60M | $76.81M |
Financial position
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Current Ratio | 0.18 | 3.34 |
| Quick Ratio | 0.11 | 2.44 |
Cash flow (trailing twelve months)
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$29.69M | -$12.35M |
| Capital Expenditures | -$213.67K | -$1.08M |
| Free Cash Flow | -$29.90M | -$20.22M |
| FCF Per Share | -$0.47 | -$0.42 |
Efficiency
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$1.39M | -$703.34K |
| Employee Count | 22 | 74 |
Dividends and yields
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -27.0% | -23.3% |
| FCF Yield | -26.4% | -8.72% |
| Buyback Yield | -17.8% | -0.59% |
| Shareholder Yield | -17.8% | 0.00% |
Shares
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 63,726,600 | 58,127,000 |
| Shares Change (QoQ) | 0.16% | 0.54% |
| Float | 48,225,800 | 49,136,700 |
| Shares Held by Insiders | 24.3% | 11.6% |
| Shares Held by Institutions | 14.1% | 59.4% |
Scores
| Measure | TuHURA Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | -2.11 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from TuHURA Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.